Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Philippines FDA/Perdinus

Approved

STANDARD

Perdinus

Serum Institute of India Private Limited🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: ae64d43b2b323697
Company: Serum Institute of India Private Limited
Type: Standard

Approval Details

Approval Id: ae64d43b2b323697
Drug Approval Philippines Name: Perdinus
Product Name: Perdinus
Registration Number: BR-324
Brand Name: Perdinus
Generic Name: Diphtheria-Tetanus Toxoids And Pertussis ( DTP ) Vaccines
Dosage Form: Suspension for Injection (IM) (Monodose)
Dosage Strength: 30 IU (25 Lf) / 40 IU (5 Lf) / 4 IU per 0.5 mL
Manufacturer: Serum Institute of India Private Limited
Importer: Genpharm, Inc.
Distributor: Genpharm, Inc.
Company Detail Path: /organization/serum-institute-of-india-private-limited
Issuance Date: 26 February 2021
Expiry Date: 28 December 2025
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

ae64d43b2b323697

Type

Standard

Back to Philippines FDA Approvals

Perdinus - Philippines FDA Drug Approval Details